Abstract
Abstract
Background
Sleeve gastrectomy with transit bipartition (SG-TB) procedure has been gaining traction recently. While being a relatively novel procedure, it shows potentials to improve the standalone SG outcomes, such as diabetes remission and reflux. This article aims to show insights on performing SG-TB in one anastomosis fashion (SG-OATB) and single-port approach.
Methods
Three patients who underwent laparoscopic single-port SG-OATB at our hospital were included. The parameters included in this study comprised of age, gender, height, weight, body mass index (BMI), type 2 diabetes mellitus (T2DM) assessment, gastroesophageal reflux disease (GERD) assessment, length of the small bowel, the duration of the procedure, and 30-day readmission rate.
Results
The mean preoperative assessments for the three patients were as follows: two females vs. one male; age 38.7 ± 5.5 years old; weight 105.7 ± 5.4 kg; height 1.64 ± 0.11 m; BMI 39.3 ± 4.7 kg/m2; fasting blood glucose 6.7 ± 1.2 mmol/L; glycosylated hemoglobin level 7.1 ± 1.3%; GERD-Questionnaire score 6.3 ± 1.5; two patients with esophagitis grade A and B following endoscopy. The total duration of the procedure was 170.0 ± 26.5 min; there was no need for conversion to multiple-port in all patients. The 30-day readmission rate for all patients was 0%.
Conclusion
In our small cases of patients, single-port SG-OATB is feasible and safe. We found the closure of the anastomosis defect to be most technically demanding. To understand better the outcome of single-port SG-OATB, studies with larger sample and longer follow-up will be needed in the future.
Funder
Medical Innovation Research Special Project of Shanghai 2022 Annual Science and Technology Innovation Action Plan
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. Ribeiro R, Viveiros O, Taranu V, Rossoni C. One anastomosis transit bipartition (OATB): rational and mid-term outcomes. Obes Surg. 2024Feb;34(2):371–81.
2. Santoro S, Velhote MCP, Malzoni CE, et al. Digestive adaptation: a new surgical proposal to treat obesity based in physiology and evolution. Einstein. 2003;1(2):99–104.
3. Widjaja J, Chu Y, Yang J, Wang J, Gu Y. Can we abandon foregut exclusion for an ideal and safe metabolic surgery? Front Endocrinol (Lausanne). 2022;10(13):1014901.
4. Kirkil C, Aydin I, Yur M, Ag O, Bozcan MY. Comparison of the ABCD score’s accuracy in predicting remission of type 2 diabetes mellitus one year after sleeve gastrectomy, one anastomosis gastric bypass, and sleeve gastrectomy with transit bipartition. Obes Surg. 2024;34(1):133–40.
5. Sewefy AM, Atyia AM, Mohammed MM, Kayed TH, Hamza HM. Single anastomosis sleeve jejunal (SAS-J) bypass as a treatment for morbid obesity, technique and review of 1986 cases and 6 Years follow-up. Retrospective Cohort Int J Surg. 2022;102:106662.